Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-012979
Filing Date
2020-06-12
Accepted
2020-06-12 09:18:09
Documents
80
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20200331_10q.htm 10-Q 679060
2 EXHIBIT 31.1 ex_189865.htm EX-31.1 9704
3 EXHIBIT 31.2 ex_189866.htm EX-31.2 10001
4 EXHIBIT 32.1 ex_189867.htm EX-32.1 4465
5 EXHIBIT 32.2 ex_189868.htm EX-32.2 4589
  Complete submission text file 0001437749-20-012979.txt   4712510

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cenb-20200331.xml EX-101.INS 896856
7 XBRL TAXONOMY EXTENSION SCHEMA cenb-20200331.xsd EX-101.SCH 68511
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20200331_cal.xml EX-101.CAL 31499
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20200331_def.xml EX-101.DEF 433208
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20200331_lab.xml EX-101.LAB 316258
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20200331_pre.xml EX-101.PRE 457617
Mailing Address 7405 TECUMSEH ROAD EAST SUITE 300 WINDSOR A6 N8T 1G2
Business Address 7405 TECUMSEH ROAD EAST SUITE 300 WINDSOR A6 N8T 1G2 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 20959057
SIC: 2834 Pharmaceutical Preparations